<code id='943EC18BDC'></code><style id='943EC18BDC'></style>
    • <acronym id='943EC18BDC'></acronym>
      <center id='943EC18BDC'><center id='943EC18BDC'><tfoot id='943EC18BDC'></tfoot></center><abbr id='943EC18BDC'><dir id='943EC18BDC'><tfoot id='943EC18BDC'></tfoot><noframes id='943EC18BDC'>

    • <optgroup id='943EC18BDC'><strike id='943EC18BDC'><sup id='943EC18BDC'></sup></strike><code id='943EC18BDC'></code></optgroup>
        1. <b id='943EC18BDC'><label id='943EC18BDC'><select id='943EC18BDC'><dt id='943EC18BDC'><span id='943EC18BDC'></span></dt></select></label></b><u id='943EC18BDC'></u>
          <i id='943EC18BDC'><strike id='943EC18BDC'><tt id='943EC18BDC'><pre id='943EC18BDC'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:6261
          Adobe

          The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

          The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

          advertisement

          The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In
          Previous article: Senators: Long
          Next article: Alkermes shareholders re

          focus

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Ukraine seeks to reclaim its role as a hub for clinical trials
          Ukraine seeks to reclaim its role as a hub for clinical trials

          AtUkraine'sDniproStateMedicalUniversity(picturedherein2013),therehasn’tbeenanewcancerdrugtrialstarte

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          FDA warns medical device makers about rise in fabricated data

          ManuelBalceCeneta/APAnincreasingnumberofmedicaldevicecompaniesaresubmittingfabricatedandunreliableda